Related Articles
Adenovirus‑mediated delivery of the human IFN‑γ gene potentiates the cytotoxicity of daunorubicin against leukemic cells through downregulation of the α4β1 integrin/ILK/apoptosis pathway
Optimization of PKH67 labeling conditions for proliferation monitoring in daunorubicin-treated leukemic cells
Inhibition of extracellular signal-regulated kinase activity by sorafenib increases sensitivity to DNR in K562 cells
HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling
Synergistic effects of LY294002 and ABT199 on the cell cycle in K562, HL60 and KG1a cells